PedAM
Pediatric Disease Annotations & Medicines
| Disease | adenocarcinoma |
| Symptom | C0242379|lung cancer |
| Sentences | 39 |
| PubMedID- 21411176 | Serum samples from 29 healthy volunteers and 33 lung cancer patients with adenocarcinoma (n=12), squamous cell carcinoma (n=11), or small cell carcinoma (n=10) ranging from stage i to stage iv disease and lung tissue samples from 7 lung cancer patients including the tumor tissue and its surrounding normal tissue were used. |
| PubMedID- 26400209 | In order to determine if mcat has any effect on naturally occurring lung cancer of the adenocarcinoma type in old mice, the tumor incidence and progression were examined in the lungs of old mcat transgenic and wild-type (wt) mice with a cb6f1 (balb/c x c57bl/6) background. |
| PubMedID- 23255847 | In conclusion, among patients with resected non-small cell lung cancer, the proportions of female, adenocarcinoma, stage ia, and lobectomy patients have increased, and the five-year survival rate has gradually improved during the last 20 yr in korea. |
| PubMedID- 23584302 | Early stage non-small-cell lung cancer: surgical implications of the new adenocarcinoma classification. |
| PubMedID- 22588153 | Four genes (tenascin-c, c-x-c motif ligand 14, s100 calcium binding protein a9, and keratin 17) were found to be upregulated in elf of non-small-cell lung cancer patients with adenocarcinoma or squamous cell carcinoma. |
| PubMedID- 25330145 | Conclusion: several unique features among patients with resected synchronous multiple lung cancers, including the presence of exclusively adenocarcinoma histology, are of prognostic significance. |
| PubMedID- 22210923 | There were statistically significantly more lung cancer-specific deaths in patients with adenocarcinoma than in patients with squamous cell carcinoma (p= 0.001). |
| PubMedID- 22566257 | A case of resected synchronous multiple primary lung cancer comprising adenocarcinoma and carcinoid (cancer-in-cancer). |
| PubMedID- 23154565 | First case of combined small-cell lung cancer with adenocarcinoma harboring eml4-alk fusion and an exon 19 egfr mutation in each histological component. |
| PubMedID- 24325900 | Unfortunately, frozen section of a subcarinal lymph node obtained at mediastinoscopy revealed metastatic poorly differentiated adenocarcinoma consistent with stage iiia lung cancer. |
| PubMedID- 25786242 | Repeating the same test using lung cancer signatures of the same type—10 adenocarcinoma signatures—did not lead to much improvement. |
| PubMedID- 20217555 | To identify and characterize novel lung adenocarcinoma genes associated with lung cancer progression, we created a bioinformatics-based approach that focuses on human cell-cycle-regulated genes that have evolved only in higher organisms but not in lower eukaryotic cells. |
| PubMedID- 24137392 | Egfr mutations, which are mostly limited to the first four exons, occur more often in lung cancer patients with adenocarcinoma histology, asian origin, female gender and a non-smoking background (13,15). |
| PubMedID- 23584303 | Early stage non-small-cell lung cancer: surgical implications of the new adenocarcinoma classification. |
| PubMedID- 20418894 | Tissue obtained from the left supraclavicular lymph node biopsy revealed a poorly differentiated adenocarcinoma resulting from lung cancer. |
| PubMedID- 21483485 | In this study, we determined the cells originating an infectious lung cancer of sheep (ovine pulmonary adenocarcinoma, opa) that is similar to some forms of human pulmonary adenocarcinoma. |
| PubMedID- 26174366 | Non-small cell lung cancer (nsclc), of which adenocarcinoma (adc) and non-adc (including squamous cell carcinoma (sqcc), large cell lung carcinoma (lcc), and bronchial gland carcinoma (bgc)) account for the majority of cases, represents almost 80 % of primary lc cases. |
| PubMedID- 24885564 | Background: although many of the recently approved genomically targeted therapies have improved outcomes for patients in non-small-cell lung cancer (nsclc) with lung adenocarcinoma, little is known about the genomic alterations that drive lung squamous cell cancer (scc) and development of effective targeted therapies in lung scc is a promising area to be further investigated. |
| PubMedID- 25859693 | Blood samples (plasma) in study 1 (fhcrc study) were taken from newly diagnosed lung cancer patients with nsclc adenocarcinoma (mostly late stage) and were frequency matched with for age, gender and for general smoking history (current and former smokers) (table 1a). |
| PubMedID- 24932312 | The present study investigated whether plasma mtdna concentrations in lung cancer patients with adenocarcinoma were altered during treatment with erlotinib, an epidermal growth factor receptor-tyrosine kinase inhibitor (egfr-tki), and whether this change has the potential to be used as a predictor of treatment response. |
| PubMedID- 22719810 | In conclusion, we investigated a lung cancer patient with lepidic predominat adenocarcinoma who had been successfully controlled with an initial treatment with gefitinib for more than 15 months, who then relapsed and was retreated with gefitinib. |
| PubMedID- 24008636 | These tumors were pathologically diagnosed as synchronous multiple primary lung cancers with adenocarcinoma and squamous cell carcinoma. |
| PubMedID- 21557161 | Chylothorax was more common on the right side, in lobectomy cases, in cases with adenocarcinoma, and in patients with advanced stage lung cancer, but the difference did not reach statistical significance. |
| PubMedID- 22969248 | When compared with patients in the old age group, females, non-smokers, and those with a more advanced stage at diagnosis and histologic type of adenocarcinoma were predominant in patients with lung cancer in the young age group. |
| PubMedID- 24811831 | Early lung cancer with lepidic pattern: adenocarcinoma in situ, minimally invasive adenocarcinoma, and lepidic predominant adenocarcinoma. |
| PubMedID- 21352550 | (p = 0.007, figure 2) post hoc tests showed that the percent of lung cancer patients with adenocarcinoma was lower in smokers than in never-smokers (64.3% versus 79.9%, p = 0.0004). |
| PubMedID- 21847065 | Alk translocation in non-small cell lung cancer with adenocarcinoma and squamous cell carcinoma markers. |
| PubMedID- 25257766 | Kras mutations are the most common mutations in non-small cell lung cancer (nsclc) with adenocarcinoma histology. |
| PubMedID- 24026853 | Second primary non-small-cell lung cancer: implications of the new adenocarcinoma classification in the challenging decision of the best surgical strategy. |
| PubMedID- 26022944 | Comparisons of the clinicopathological features and survival outcomes between lung cancer patients with adenocarcinoma and squamous cell carcinoma. |
| PubMedID- 23617234 | In this report, we described a case of synchronous bilateral lung cancers with eml4-alk positive adenocarcinoma in the right lung and adenocarcinoma in situ in the left, which was eml4-alk negative. |
| PubMedID- 22729036 | High expression of folate receptor alpha in lung cancer correlates with adenocarcinoma histology and egfr corrected mutation. |
| PubMedID- 22429580 | We identified the dynamic changes of the immune system by investigating the levels of t lymphocyte subsets in peripheral blood of lung cancer patients with advanced stage adenocarcinoma undergoing first line chemotherapy. |
| PubMedID- 22253823 | Nsclc accounts for about 80% of all lung cancer cases, with adenocarcinoma predominating. |
| PubMedID- 26161361 | The loss of blood group antigen a expression has a negative prognostic impact in stage i non-small cell lung cancer, especially in patients with adenocarcinoma (265). |
| PubMedID- 23494387 | lung cancer patients with adenocarcinoma histology may benefit most from treg-targeted therapy. |
| PubMedID- 23180523 | lung cancer, including adenocarcinoma, was the most common type of malignancy, present in 44 (67%) patients. |
| PubMedID- 26010604 | Nsclc comprises 85% of all lung cancer cases, with adenocarcinoma (ac) representing the major histological subtype of nsclc 1. |
| PubMedID- 21611070 | Biopsy of the lesion revealed a low grade adenocarcinoma, consistent with a primary lung cancer. |
Page: 1